glp 1 health risks GLP-1 Agonist: The Good, the Bad and the Ugly Unlocking the broad health benefits

Downregulation of the kidney glucagon receptor, essential for renal function and systemic homeostasis, contributes to chronic kidney disease

Combining genetic insights with clinical monitoring creates a truly personalized weight-loss strategy

Patients on those medications dont stop when their numbers normalize

we conducted an additional analysis in which patients with any non-thyroid cancer at any time before cohort entry were excluded

Gallbladder Issues Research shows an increase in gallbladder-related issues in GLP-1 medication users, with conditions ranging from asymptomatic gallstones to severe cholecystitis requiring surgical intervention

Large employer health benefit plans increasingly include GLP-1 medications in formularies, though typically with prior authorization requirements and step therapy protocols